Drug Pipeline

DOAC Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05955365 Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing… Percutaneous Coronary Intervention (PCI) Recruiting
Phase 3
NCT05825573 Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus Intracardiac Thrombus Active, Not Recruiting
Phase 2
NCT05498428 A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including… Carcinoma, Non-small-Cell Lung Recruiting
Not specified
NCT05976685 Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic… Ischemic Stroke Recruiting
Sponsors Running DOAC Trials
Insel Gruppe AG, University Hospital Bern (2) Janssen Research & Development, LLC (1) Centre Hospitalier Universitaire de Nīmes (1)
Disease Areas
Atrial Fibrillation (2) Non-Small Cell Lung Cancer (NSCLC) (1) Heart Failure (1) Stroke (1)
Get alerts when DOAC trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free